Medtech / devices

  • Weight loss jabs my only temporarily reduce ‘food noise,’ study finds

    Brain recordings show tirzepatide briefly silences food noise in one woman with obesity, but the effect appears temporary. A rare brain study using implanted electrodes found that tirzepatide, sold as Mounjaro and Zepbound, quiets brain signals linked to constant thoughts about food, but the effect appears temporary. Researchers monitored brain activity in a 60-year-old woman [...]

  • Supplement could restore memories lost by Alzheimer’s, study finds

    A naturally occurring supplement could restore memory loss in Alzheimer’s, a mouse study using human gene mutations suggests. Nicotinamide adenine dinucleotide (NAD+) is a molecule vital for energy production, DNA repair and cellular health, often discussed by longevity specialists as a tool against age-related disease. Researchers have discovered it can protect the brain from degeneration [...]

  • Forus gains AI backing with 21 per cent stake

    Eye-screening firm Forus Health has received a 21 per cent investment to scale its AI diagnostics across India and abroad. Forus Health develops ophthalmic diagnostics — tools that detect eye disease — and “oculomics”, which uses eye images to flag wider risks such as diabetes or hypertension. Its devices have screened over 22 million people [...]

  • Scientists closer to halting ageing at its biological roots

    British scientists are preparing human trials of an anti-ageing pill, claiming they can curb age-related tissue decline. The team says research has found a way to block necrosis — uncontrolled cell death linked to many age-related diseases. If successful, doctors could move beyond treating symptoms of ageing to targeting the biological processes that cause it. [...]

  • Common diabetes drug may be cancelling out exercise benefits

    The widely used diabetes drug, metformin, may weaken the gains from exercise, new research suggests. More than 450 million people across the world have type 2 diabetes, and treatment often hinges on lifestyle changes alongside medication. For nearly half a century, doctors have prescribed metformin and recommended daily physical activity to diabetes patients, on the [...]

  • Engineered ‘young’ immune cells could help to reverse Alzheimer’s damage

    Lab-grown immune cells improved memory and reduced brain damage in ageing and Alzheimer’s mice, suggesting a possible new way to treat the condition. The engineered cells, developed from human stem cells, appeared to reverse some effects of ageing and brain damage caused by disease in mouse models. These immune cells, known as mononuclear phagocytes, normally [...]

  • Blood tests ‘could revolutionise dementia diagnosis,’ expert says

    A trial into blood tests for dementia could change diagnosis and care for millions, with around one-third of UK patients still undiagnosed. A major study is examining both new and existing biomarker-based blood tests to help close the diagnosis gap that prevents many people from accessing new dementia treatments. Biomarkers are biological indicators in the [...]

  • Rendever secures nearly US$4.5m to fight isolation

    Virtual reality firm Rendever has secured nearly US$4.5m in grants to tackle social isolation among older adults through immersive technology. The funding from the National Institutes of Health (NIH) includes US$3.8m for the Thrive At Home Program and an additional grant to build a caregiver support network in VR. These funds will enable Rendever to [...]

  • Citrus and grapes may protect against type 2 diabetes

    A daily blend of citrus and grape extracts with chromium normalised blood sugar in people with prediabetes within six months during a recent study, outperforming diet alone. The six-month clinical trial found that a supplement containing citrus and red grape extracts, chromium and hesperidin helped people with impaired fasting glucose – a prediabetic condition – [...]

  • CareScout completes Seniorly acquisition

    CareScout has completed its purchase of Seniorly, with the adviser network and partners to migrate to the CareScout platform in the coming months. CareScout said the deal strengthens its direct-to-consumer capabilities and accelerates plans to help families understand, find and pay for long-term care — ongoing support with daily activities such as bathing, dressing and [...]